Literature DB >> 24599785

Achieving allocative efficiency in healthcare: nice in theory, not so NICE in Practice?

Mike Paulden1, Christopher McCabe, Jonathan Karnon.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24599785     DOI： 10.1007/s40273-014-0146-x

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN： 1170-7690            Impact factor:   4.981


× No keyword cloud information.
  10 in total

1.  Real economics needs to reflect real decisions: a response to Johnson.

Authors:  Mark Sculpher; Karl Claxton
Journal:  Pharmacoeconomics       Date:  2012-02-01       Impact factor: 4.981

2.  What is value in health care?

Authors:  Michael E Porter
Journal:  N Engl J Med       Date:  2010-12-08       Impact factor: 91.245

3.  Value based pricing for NHS drugs: an opportunity not to be missed?

Authors:  Karl Claxton; Andrew Briggs; Martin J Buxton; Anthony J Culyer; Christopher McCabe; Simon Walker; Mark J Sculpher
Journal:  BMJ       Date:  2008-02-02

Review 4.  The NICE cost-effectiveness threshold: what it is and what that means.

Authors:  Christopher McCabe; Karl Claxton; Anthony J Culyer
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981

5.  Disinvestment from low value clinical interventions: NICEly done?

Authors:  Sarah Garner; Peter Littlejohns
Journal:  BMJ       Date:  2011-07-27

6.  Over 150 potentially low-value health care practices: an Australian study.

Authors:  Adam G Elshaug; Amber M Watt; Linda Mundy; Cameron D Willis
Journal:  Med J Aust       Date:  2012-11-19       Impact factor: 7.738

7.  Can the real opportunity cost stand up: displaced services, the straw man outside the room.

Authors:  Simon Eckermann; Brita Pekarsky
Journal:  Pharmacoeconomics       Date:  2014-04       Impact factor: 4.981

8.  Applying risk adjusted cost-effectiveness (RAC-E) analysis to hospitals: estimating the costs and consequences of variation in clinical practice.

Authors:  Jonathan Karnon; Orla Caffrey; Clarabelle Pham; Richard Grieve; David Ben-Tovim; Paul Hakendorf; Maria Crotty
Journal:  Health Econ       Date:  2012-04-30       Impact factor: 3.046

9.  Decision analysis for resource allocation in health care.

Authors:  Susan Griffin; Karl Claxton; Mark Sculpher
Journal:  J Health Serv Res Policy       Date:  2008-10

10.  Searching for a threshold, not setting one: the role of the National Institute for Health and Clinical Excellence.

Authors:  Anthony Culyer; Christopher McCabe; Andrew Briggs; Karl Claxton; Martin Buxton; Ron Akehurst; Mark Sculpher; John Brazier
Journal:  J Health Serv Res Policy       Date:  2007-01
  10 in total
  3 in total

1.  Are current cost-effectiveness thresholds for low- and middle-income countries useful? Examples from the world of vaccines.

Authors:  A T Newall; M Jit; R Hutubessy
Journal:  Pharmacoeconomics       Date:  2014-06       Impact factor: 4.981

2.  NICE's cost-effectiveness range: should it be lowered?

Authors:  J P Raftery
Journal:  Pharmacoeconomics       Date:  2014-07       Impact factor: 4.981

3.  Ethical Hurdles in the Prioritization of Oncology Care.

Authors:  Folkert de Groot; Stefano Capri; Jean-Claude Castanier; David Cunningham; Bruno Flamion; Mathias Flume; Harald Herholz; Lars-Åke Levin; Oriol Solà-Morales; Christoph J Rupprecht; Natalie Shalet; Andrew Walker; Olivier Wong
Journal:  Appl Health Econ Health Policy       Date:  2017-04       Impact factor: 2.561
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.